Think as a nutrigenecist and change the following recommendations for a client with high GENETIC risk of Leukomia : Ensure adequate folate (leafy greens, legumes, fortified cereals) and vitamin B12 - critical for normal haemopoiesis and DNA integrity Eat a diet rich in antioxidants (vitamins C and E, selenium, carotenoids) from colourful fruits and vegetables Include cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) - sulforaphane has demonstrated anti-leukaemic activity in preclinical studies Avoid alcohol - alcohol impairs folate metabolism and is associated with increased risk of myeloid malignancies For Fanconi anaemia and Li-Fraumeni associated leukaemia risk: prioritise folate, B12, and antioxidant-rich foods Maintain a healthy body weight - obesity is associated with increased AML risk
Searching PubMed
folate nutrition leukemia genetic risk DNA methylation
Searching PubMed
sulforaphane leukemia anti-leukemic nutrigenomics
Searching the Web
nutrigenomics leukemia genetic risk dietary recommendations folate B12 antioxidants 2024 2025
Searching PubMed
diet leukemia prevention polyphenols phytochemicals AML CLL
Searching PubMed
MTHFR folate leukemia risk one-carbon metabolism methylation
Reading Article
PMID: 41338873
Reading Web Page
https://www.mdpi.com/2072-6643/16/23/4100
Now I have enough to write a thorough, evidence-informed nutrigenomics response. Here are the revised and significantly enhanced recommendations:
Nutrigenomics-Informed Dietary Recommendations
Client Profile: High Genetic Risk of Leukaemia
1. FOLATE AND B12 - Precision Over Simplicity
Original: Ensure adequate folate and B12 from leafy greens, legumes, and fortified cereals.
Revised (Nutrigenomics Lens):
- First, establish MTHFR status. The client's MTHFR C677T and A1298C genotype determines how efficiently dietary folate is converted to its active form (5-methyltetrahydrofolate). If a hypomorphic variant is present, standard dietary folate may be insufficient - prioritise methylfolate-rich foods (dark leafy greens, asparagus, avocado, lentils) and consider 5-MTHF supplemental forms rather than synthetic folic acid.
- Timing matters: Meta-analyses consistently report that adequate folate during the periconceptional period is protective against ALL (Xiang et al., 2025, PMID 41338873). For an adult at risk, ongoing adequacy - not excess - is the target.
- Avoid very high-dose folic acid supplementation without testing. Unmetabolised folic acid can paradoxically mask true B12 deficiency and may have pro-proliferative effects in the context of existing pre-malignant clones.
- B12 co-sufficiency is non-negotiable: Folate metabolism is B12-dependent. Without adequate B12, SAM (S-adenosylmethionine) synthesis is impaired, disrupting DNA methylation and increasing genomic instability - a key driver of haematological malignancy.
- Sources to prioritise: Spinach, rocket, broccoli, asparagus, lentils, chickpeas (folate); eggs, sardines, fortified nutritional yeast, dairy (B12). For vegans/vegetarians, B12 supplementation is essential.
2. ANTIOXIDANTS - Genotype-Directed Selection
Original: Eat a diet rich in antioxidants (vitamins C and E, selenium, carotenoids) from colourful fruits and vegetables.
Revised (Nutrigenomics Lens):
- SOD2, CAT, GPX1 and NQO1 variants affect the client's endogenous antioxidant capacity. If the client carries the NQO1*2 null polymorphism (common in therapy-related AML and ALL risk), quinone-mediated oxidative stress is poorly managed - dietary antioxidants become more critical as a compensatory strategy.
- Polyphenol-specific targets based on evidence:
- Green tea (EGCG): Demonstrated FLT3 inhibition, PI3K/AKT pathway suppression, and cell cycle arrest in AML cell lines. Target: 2-3 cups daily of matcha or green tea. Avoid with iron-rich meals (EGCG chelates iron).
- Resveratrol (grapes, red berries, peanut skins): Pro-apoptotic effects in ALL and AML, including caspase activation and epigenetic modification. Modest dietary amounts are achievable; supplementation remains under study.
- Anthocyanins (blueberries, black currants, cherries): Blueberry extracts show anti-AML activity via Akt and Erk pathway regulation in leukemic stem cells. Target: 1 cup/day of mixed dark berries.
- Quercetin (red onions, capers, apples): Inhibits leukemia cell proliferation and sensitises cells to apoptotic signals.
- Carotenoids (lycopene, beta-carotene, lutein) from tomatoes, sweet potato, and orange/yellow vegetables support genomic stability. Prefer whole foods over isolated supplements - the food matrix matters for bioavailability.
- Selenium: Cofactor for glutathione peroxidase and thioredoxin reductase. Selenium adequacy (not excess - toxicity occurs above ~400 mcg/day) supports DNA repair. Sources: Brazil nuts (1-2/day max), sunflower seeds, tuna, eggs.
- Vitamin C: High-dose IV vitamin C has shown cytotoxicity in leukaemia cell lines, but dietary doses remain anti-inflammatory and support iron regulation. Target: 500-1000 mg/day from food and low-dose supplementation.
3. CRUCIFEROUS VEGETABLES - Mechanistically Strengthen the Rationale
Original: Include cruciferous vegetables - sulforaphane has demonstrated anti-leukaemic activity in preclinical studies.
Revised (Nutrigenomics Lens):
- The anti-leukaemic benefit of sulforaphane is strongly linked to NRF2 pathway activation, which upregulates endogenous antioxidant and detoxification enzymes (HO-1, NQO1, GST). The magnitude of this effect is partly determined by the client's GSTM1/GSTT1 genotype - null variants reduce sulforaphane metabolite activity, making dietary intake even more important.
- Indole-3-carbinol (I3C) and diindolylmethane (DIM) from cruciferous vegetables modulate aryl hydrocarbon receptor (AhR) signalling, which has downstream effects on haematopoietic cell differentiation - directly relevant to myeloid and lymphoid leukaemia biology.
- Practical targets: 3-5 servings per week minimum of broccoli, kale, Brussels sprouts, bok choy, radish. Lightly steam rather than boil - boiling leaches glucosinolates by up to 60%. Chewing raw or lightly cooked is ideal to maximise myrosinase activity (required for sulforaphane release).
- Pair with myrosinase co-factors: Adding mustard powder, daikon radish, or raw rocket to cooked broccoli restores sulforaphane production when myrosinase is heat-denatured.
4. ALCOHOL - Mechanistically Explicit
Original: Avoid alcohol - it impairs folate metabolism and is associated with increased risk of myeloid malignancies.
Revised (Nutrigenomics Lens):
- Zero tolerance is appropriate for this client. The recommendation to "avoid" should be unambiguous and absolute, not a soft reduction target.
- Mechanistically: Ethanol directly inhibits methionine synthase and disrupts the methylation cycle, depleting SAM. In a client with potential MTHFR variants or existing methylation pathway stress, even low-to-moderate alcohol intake can tip the balance toward hypomethylation of tumour suppressor gene promoters.
- Acetaldehyde (the primary toxic metabolite of alcohol) is a direct DNA cross-linking agent. ALDH2 variants (particularly ALDH2*2, common in East Asian clients) dramatically increase acetaldehyde accumulation, massively elevating leukaemia risk from any alcohol exposure.
- Alcohol and folate competition is bidirectional: Alcohol impairs intestinal folate absorption, disrupts hepatic folate storage, and increases urinary folate excretion simultaneously. This triple depletion mechanism is especially dangerous when the client's leukaemia risk is already genetically elevated.
5. FANCONI ANAEMIA / LI-FRAUMENI SPECIFIC NUTRITION - Significantly Expand
Original: For Fanconi anaemia and Li-Fraumeni associated leukaemia risk: prioritise folate, B12, and antioxidant-rich foods.
Revised (Nutrigenomics Lens):
Fanconi Anaemia (FANC gene mutations - FANCA, FANCC, FANCD2, etc.):
- The Fanconi pathway is responsible for inter-strand DNA crosslink repair. Dietary strategy should minimise exogenous crosslinking agents: avoid smoked, cured, and charred meats (major sources of dietary crosslinking agents and alkylating compounds). Strict avoidance of aflatoxin-contaminated foods (mouldy nuts, grains).
- Antioxidant load is the centrepiece - oxidative stress directly overwhelms the FA repair pathway. Prioritise Vitamin E (tocopherols + tocotrienols, not just alpha-tocopherol), vitamin C, and selenium synergistically.
- Androgen-stimulating foods (high-dose phytoestrogens, licorice, unfermented soy in excess) should be used cautiously - androgenic stimulation is a treatment modality in FA but dietary amounts are unlikely to be therapeutic.
- Iron status monitoring: Many FA clients develop aplastic anaemia and may receive blood transfusions - iron overload becomes a separate oxidative stress risk. A nutrigenomicist should assess iron status carefully before recommending iron-rich foods or supplements.
Li-Fraumeni (TP53 germline mutation):
- p53 is a master guardian of the genome. Nutritional support should focus on compounds that support p53 function or compensate for its loss: resveratrol maintains wild-type p53 expression; quercetin stabilises p53 protein and inhibits MDM2-mediated p53 degradation.
- IGF-1 signalling is a key driver of cancer promotion in TP53 carriers. Reduce dietary IGF-1 stimulation: moderate (not eliminate) animal protein intake, limit refined carbohydrates and high-glycaemic foods that spike insulin/IGF-1.
- Phytochemicals that activate AMPK (berberine from plant sources, sulforaphane, curcumin) support metabolic cancer suppression pathways that partially compensate for p53 loss.
- Folate and B12 remain relevant (DNA fidelity), but the overarching strategy shifts toward reducing replication stress and inflammation, not just haematopoietic support.
6. BODY WEIGHT - Add the Nutrigenomics Layer
Original: Maintain a healthy body weight - obesity is associated with increased AML risk.
Revised (Nutrigenomics Lens):
- Obesity drives leukaemia risk primarily through chronic low-grade inflammation (elevated IL-6, TNF-alpha, CRP), hyperinsulinaemia/IGF-1 excess, and bone marrow adiposity (adipocytes in the marrow niche directly fuel leukaemic stem cell metabolism via fatty acid oxidation).
- Genotype considerations: FTO, MC4R, and PPARG variants affect adiposity trajectory. If the client carries FTO risk alleles, protein-adequate, lower-glycaemic dietary patterns are more effective for weight maintenance than standard caloric restriction alone.
- Dietary strategy beyond calories:
- Anti-inflammatory dietary patterns (Mediterranean, MIND-style): reduce bone marrow adiposity independent of total body weight.
- Reduce ultra-processed foods aggressively - beyond calories, UPFs contain emulsifiers, advanced glycation end-products (AGEs), and nitrite preservatives that contribute directly to haematopoietic oxidative stress.
- Intermittent caloric restriction or time-restricted eating (e.g., 16:8): reduces IGF-1 and insulin without requiring dramatic caloric deficit. Evidence from cancer biology supports AMPK activation and autophagy upregulation as anti-tumourigenic mechanisms.
- Muscle mass preservation is as important as fat loss: Sarcopenic obesity carries higher leukaemia progression risk than obesity alone. Ensure adequate leucine-rich protein (eggs, legumes, fish) to maintain lean mass.
ADDITIONAL NUTRIGENOMICS-SPECIFIC RECOMMENDATIONS (Not in Original List)
7. Epigenetic Nutrition - One-Carbon Metabolism Network
- Beyond folate and B12, optimise the full methylation network: choline (eggs, liver, soybeans), methionine (animal proteins, sesame seeds), betaine (beetroot, quinoa, spinach), and riboflavin (B2, required as MTHFR cofactor). This is especially relevant for MTHFR variant carriers.
- Zinc is a cofactor for multiple DNA repair enzymes (PARP, DNA-PK). Deficiency impairs double-strand break repair. Sources: pumpkin seeds, oysters, legumes, hemp seeds.
8. Curcumin and Phytochemical Epigenetic Modulators
- Curcumin (turmeric) inhibits NF-kB and HDAC, with specific anti-leukaemic activity in CLL, AML, and ALL cell lines. Bioavailability is poor without piperine (black pepper) or fat as a carrier. Target: fresh turmeric in cooked meals + black pepper.
- EGCG (green tea), apigenin (parsley, chamomile), and genistein (fermented soy) are dietary DNMT inhibitors - relevant since aberrant DNA methylation of tumour suppressor genes is a hallmark of leukaemogenesis.
9. Gut Microbiome and Immune Surveillance
- Prebiotic fibre (chicory, Jerusalem artichoke, garlic, leeks, oats) supports short-chain fatty acid (SCFA) production. Butyrate and propionate inhibit HDAC in haematopoietic cells, supporting normal differentiation and suppressing leukaemic clone expansion.
- Fermented foods (kefir, kimchi, miso, live-culture yogurt) modulate innate immune tone. A healthy gut microbiome is now recognised as part of the immuno-surveillance ecosystem against haematological malignancies.
10. Avoid Known Haematopoietic Toxins
- Benzene sources: avoid processed petrol station food, excessive cured meats, heavily charred/barbecued foods. Benzene is the most established dietary-environmental leukaemogen.
- Pesticide residue: Organophosphate and organochlorine pesticides are associated with elevated AML/ALL risk. Prioritise organic versions of the "dirty dozen" produce (strawberries, spinach, apples, grapes). Wash all produce thoroughly.
- Artificial sweeteners and dyes: Emerging data implicates some artificial food colorants (Red 40, Yellow 5) in haematopoietic stress - minimise ultra-processed foods carrying synthetic additives.
Summary Table
| Domain | Original Focus | Nutrigenomics Upgrade |
|---|---|---|
| Folate/B12 | Adequacy | MTHFR genotype-directed form and dose |
| Antioxidants | General colours | Polyphenol class selection (EGCG, anthocyanins, quercetin) by mechanism |
| Cruciferous veg | Sulforaphane | GSTM1/NRF2 genotype; myrosinase activation technique |
| Alcohol | Avoid | Zero tolerance; ALDH2 genotype amplifies risk |
| FA/LFP | Folate + antioxidants | Crosslink avoidance (FA); p53/IGF-1 axis (LFS) |
| Body weight | Obesity risk | Bone marrow adiposity; FTO genotype; IGF-1 suppression; anti-inflammatory dietary pattern |
| NEW | - | One-carbon methylation network; epigenetic phytochemicals; gut microbiome; environmental toxin avoidance |
Note for clinical practice: These recommendations are intended as a nutrigenomics-informed framework. Actual implementation should be personalised to confirmed genotyping results (MTHFR, GSTM1/T1, NQO1, ALDH2, FTO, TP53 status), current labs (serum folate, B12, homocysteine, ferritin, selenium, inflammatory markers), and any active haematology surveillance programme. A nutrigenomicist works alongside, not instead of, the haematology team.
share in 8-10 lines as a recommendation
Nutrigenomics Recommendations – High Genetic Risk of Leukaemia
-
Establish MTHFR genotype first - if a variant is present, prioritise methylfolate-rich foods (dark leafy greens, lentils, asparagus) and avoid high-dose synthetic folic acid, which may have pro-proliferative effects in pre-malignant states.
-
Maintain B12 co-sufficiency alongside folate - without adequate B12, the methylation cycle stalls, impairing DNA repair and tumour suppressor gene expression; include eggs, sardines, and dairy or supplement if vegan.
-
Target polyphenol-specific foods by mechanism - green tea (2-3 cups/day) for FLT3/PI3K-AKT inhibition, blueberries for Akt/Erk regulation in leukaemic stem cells, and red onions/apples for quercetin-mediated pro-apoptotic effects.
-
Optimise cruciferous vegetable preparation - lightly steam broccoli and kale (3-5 servings/week) and add raw mustard or daikon to restore myrosinase activity; sulforaphane benefit is also genotype-dependent (GSTM1/NRF2 variants).
-
Support the full one-carbon methylation network - beyond folate and B12, include choline (eggs, soybeans), betaine (beetroot, quinoa), and riboflavin (B2), which is the essential MTHFR enzyme cofactor.
-
Zero alcohol - no threshold is safe here - alcohol simultaneously depletes folate absorption, storage, and excretion while acetaldehyde directly crosslinks DNA; clients with ALDH2 variants face dramatically amplified risk even from small amounts.
-
Reduce IGF-1 and insulin stimulation - limit refined carbohydrates and ultra-processed foods; for Li-Fraumeni (TP53) carriers in particular, chronic IGF-1 elevation drives cancer promotion when p53-mediated suppression is compromised.
-
Support gut microbiome for immune surveillance - include prebiotic fibre (garlic, leeks, oats) to generate butyrate, which inhibits HDAC activity in haematopoietic cells and supports normal cell differentiation over leukaemic clone expansion.
-
Minimise haematopoietic toxin exposure - choose organic for high-pesticide produce, avoid charred and heavily cured meats (benzene, AGEs, nitrites), and reduce synthetic food additives - all of which impose direct oxidative and genotoxic stress on bone marrow.
-
Frame weight management around bone marrow adiposity, not just BMI - bone marrow fat directly fuels leukaemic stem cell metabolism; an anti-inflammatory dietary pattern (Mediterranean-style) with adequate lean protein reduces marrow adiposity independent of total body weight.
For Liver cancer : Follow a Mediterranean dietary pattern - anti-inflammatory, anti-fibrotic, supports liver health Limit red and processed meat Avoid alcohol entirely - even moderate alcohol dramatically accelerates liver fibrosis and HCC risk in those with genetic liver disease (hemochromatosis, alpha-1 antitrypsin deficiency, Wilson's disease) Coffee (2-4 cups/day) - among the most consistent dietary associations with reduced HCC risk and cirrhosis progression; a reasonable daily habit Avoid herbal supplements not approved by your doctor - many contain hepatotoxic compounds Avoid: Aflatoxin-contaminated foods (improperly stored grains and nuts in humid climates); raw freshwater fish (liver fluke risk) Adequate vitamin D - supports immune surveillance and liver cell differentiation For hemochromatosis: limit iron-rich foods (red meat, offal) and avoid vitamin C supplements (increase iron absorption); avoid alcohol Maintain a healthy weight - obesity-driven NAFLD is a direct pathway to liver cancer Consume Omega-3 fatty acid foods like fatty fish, flax seeds, Chia seeds, or walnuts to reduce HCC risk Limit or eliminate fructose and added sugars to reduce non-alcoholic fatty liver disease (NAFLD) progression, as NAFLD is strongly related to HCC Avoid dietary supplements containing iron or kava kava
Nutrigenomics-Informed Recommendations – High Genetic Risk of Liver Cancer (HCC)
-
Genotype-direct the Mediterranean pattern - confirm PNPLA3 (I148M), TM6SF2, and MBOAT7 variants first; carriers of PNPLA3 rs738409 have 3-5x elevated NAFLD-to-HCC progression risk and respond more strongly to reduced saturated fat and fructose than the general population, making dietary precision - not just pattern adherence - the priority.
-
Eliminate alcohol with zero exceptions - in genetic liver disease (HFE hemochromatosis, ATP7B Wilson's disease, SERPINA1 alpha-1 antitrypsin deficiency), alcohol synergises with the primary mutation to accelerate hepatocyte injury, fibrosis, and malignant transformation through shared oxidative and inflammatory pathways; no safe threshold exists for this client.
-
For hemochromatosis (HFE C282Y/H63D carriers): apply strict iron restriction - avoid red meat, offal, iron-fortified cereals, and cast-iron cookware; eliminate vitamin C supplements entirely as ascorbic acid dramatically increases non-haem iron absorption and accelerates iron-mediated Fenton chemistry and hepatocyte DNA damage; prioritise polyphenol-rich teas with meals (tannic acid competitively inhibits iron absorption).
-
For Wilson's disease (ATP7B variants): implement copper-aware eating - restrict shellfish (especially oysters), liver, chocolate, nuts, and mushrooms; cooking in copper vessels is contraindicated; zinc-rich foods (pumpkin seeds, legumes) competitively inhibit intestinal copper absorption via metallothionein induction and are a recognised dietary adjunct to chelation therapy.
-
Target fructose and added sugars aggressively - fructose is exclusively hepatically metabolised, drives de novo lipogenesis, depletes hepatic ATP, and generates uric acid - a direct NLRP3 inflammasome activator; in PNPLA3/TM6SF2 variant carriers, fructose-driven lipid accumulation is amplified; eliminate sugar-sweetened beverages, fruit juices, and ultra-processed snacks entirely, and limit whole fruit to 1-2 low-fructose servings/day (berries, citrus).
-
Leverage coffee's hepatoprotective mechanisms deliberately - 2-4 cups/day of filtered or espresso coffee reduces HCC risk and cirrhosis progression via NRF2 activation, NF-kB suppression, and direct antifibrotic effects on hepatic stellate cells; kahweol and cafestol (diterpenes in unfiltered coffee) add HDAC-inhibitory and anti-inflammatory effects - instant coffee retains caffeic acid benefits but lacks diterpenes; this is a tier-1 dietary intervention for this client.
-
Prioritise omega-3 fatty acids with genotype awareness - EPA and DHA (fatty fish: salmon, sardines, mackerel) reduce hepatic inflammation and steatosis via PPAR-alpha activation and SREBP-1c suppression; clients with FADS1/FADS2 variants have impaired ALA-to-EPA/DHA conversion, making plant-based sources (flax, chia, walnuts) insufficient alone - oily fish 3x/week or algae-based DHA is the reliable route.
-
Aflatoxin B1 zero tolerance - absolute, not aspirational - AFB1 is bioactivated by CYP1A2 and CYP3A4 to an epoxide that forms AFB1-N7-guanine adducts, causing the TP53 R249S hotspot mutation found in 30-60% of HCC in high-exposure regions; those with slow CYP detoxification variants face higher adduct accumulation; store all nuts and grains in dry, cool, sealed containers and discard any with visible mould.
-
Support hepatic glutathione synthesis and phase II detoxification - cruciferous vegetables (broccoli, kale, Brussels sprouts) activate NRF2-driven glutathione-S-transferase expression, directly enhancing hepatic detoxification capacity; N-acetylcysteine precursor foods (high-sulphur foods: eggs, garlic, onions) support glutathione replenishment; this is especially relevant for alpha-1 antitrypsin deficiency where accumulated misfolded protein generates sustained ER and oxidative stress.
-
Eliminate all unsupervised herbal and iron supplements; add vitamin D with testing - pyrrolizidine alkaloids (comfrey, borage), germander, kava kava, and many traditional hepatic "tonics" are direct hepatotoxins that compound genetic liver disease; vitamin D sufficiency (target 25-OHD 50-80 nmol/L) supports hepatic immune surveillance and VDR-mediated antifibrotic signalling - test first, supplement to target, and recheck every 6 months.
-
Weight management via liver-specific metabolic levers - beyond BMI, target visceral and intrahepatic fat reduction; time-restricted eating (14:10 or 16:8) reduces hepatic lipid accumulation and insulin resistance independently of caloric restriction, particularly beneficial for PNPLA3 variant carriers; preserve lean muscle mass with adequate leucine-rich protein (eggs, legumes, fish) to prevent sarcopenic obesity, which carries additive HCC risk beyond adiposity alone.
Clinical note: Recommendations should be integrated with confirmed genotyping (HFE, ATP7B, SERPINA1, PNPLA3, TM6SF2, FADS1/2, CYP1A2), liver function tests, ferritin/transferrin saturation (hemochromatosis), ceruloplasmin (Wilson's), and serum 25-OHD. A nutrigenomicist works within the hepatology-led multidisciplinary team for this high-risk client.
Create a nutrigenomics dietary protocol document for liver cancer genetic risk clients
Reading File
Reading File
Running Command
mkdir -p /home/daytona/workspace/liver-cancer-protocol && ls /home/daytona/works…
Writing File
~/liver-cancer-protocol/generate.js
const {
Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
Header, Footer, AlignmentType, HeadingLevel, BorderStyle, WidthType,
ShadingType, VerticalAlign, PageNumber, LevelFormat, UnderlineType
} = require('docx');
const fs = require('fs');
// ── Colour palette ──────────────────────────────────────────────────
const DARK_GREEN = "1A4731"; // section headings
const MID_GREEN = "2D6A4F"; // sub-headings
const ACCENT = "52B788"; // table header bg
const LIGHT_GREEN = "D8F3DC"; // alternate row / callout bg
const DARK_TEXT = "1B1B1B";
const WHITE = "FFFFFF";
const WARN_RED = "C1121F";
const WARN_BG = "FFE8E8";
// ── Helper: shaded paragraph (callout box) ──────────────────────────
function callout(text, bg = LIGHT_GREEN, bold = false, color = DARK_TEXT) {
return new Paragraph({
shading: { type: ShadingType.CLEAR, fill: bg },
spacing: { before: 80, after: 80 },
indent: { left: 360, right: 360 },
children: [new TextRun({ text, bold, color, font: "Arial", size: 20 })]
});
}
// ── Helper: heading 1 ───────────────────────────────────────────────
function h1(text) {
return new Paragraph({
heading: HeadingLevel.HEADING_1,
spacing: { before: 300, after: 120 },
children: [new TextRun({ text, bold: true, color: WHITE, font: "Arial", size: 28 })],
shading: { type: ShadingType.CLEAR, fill: DARK_GREEN }
});
}
// ── Helper: heading 2 ───────────────────────────────────────────────
function h2(text) {
return new Paragraph({
heading: HeadingLevel.HEADING_2,
spacing: { before: 200, after: 80 },
children: [new TextRun({ text, bold: true, color: WHITE, font: "Arial", size: 24 })],
shading: { type: ShadingType.CLEAR, fill: MID_GREEN }
});
}
// ── Helper: heading 3 ───────────────────────────────────────────────
function h3(text) {
return new Paragraph({
spacing: { before: 160, after: 60 },
children: [new TextRun({ text, bold: true, color: DARK_GREEN, font: "Arial", size: 22, underline: { type: UnderlineType.SINGLE } })]
});
}
// ── Helper: body paragraph ──────────────────────────────────────────
function body(text, bold = false, color = DARK_TEXT) {
return new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text, bold, color, font: "Arial", size: 20 })]
});
}
// ── Helper: bullet item ─────────────────────────────────────────────
function bullet(label, detail, warnMode = false) {
return new Paragraph({
numbering: { reference: "bullets", level: 0 },
spacing: { before: 40, after: 40 },
children: [
new TextRun({ text: label + ": ", bold: true, color: warnMode ? WARN_RED : DARK_GREEN, font: "Arial", size: 20 }),
new TextRun({ text: detail, font: "Arial", size: 20, color: DARK_TEXT })
]
});
}
// ── Helper: plain bullet ────────────────────────────────────────────
function plainBullet(text) {
return new Paragraph({
numbering: { reference: "bullets", level: 0 },
spacing: { before: 40, after: 40 },
children: [new TextRun({ text, font: "Arial", size: 20, color: DARK_TEXT })]
});
}
// ── Helper: numbered bullet ─────────────────────────────────────────
function numBullet(text, ref = "numbers") {
return new Paragraph({
numbering: { reference: ref, level: 0 },
spacing: { before: 40, after: 40 },
children: [new TextRun({ text, font: "Arial", size: 20, color: DARK_TEXT })]
});
}
// ── Helper: spacer ──────────────────────────────────────────────────
function spacer(n = 1) {
return Array(n).fill(null).map(() => new Paragraph({ spacing: { before: 40, after: 40 }, children: [new TextRun("")] }));
}
// ── Helper: table cell ──────────────────────────────────────────────
function tc(text, bg = WHITE, bold = false, color = DARK_TEXT, width = null) {
const opts = {
shading: { type: ShadingType.CLEAR, fill: bg },
verticalAlign: VerticalAlign.CENTER,
margins: { top: 80, bottom: 80, left: 120, right: 120 },
children: [new Paragraph({
children: [new TextRun({ text, bold, color, font: "Arial", size: 18 })],
alignment: AlignmentType.LEFT
})]
};
if (width) opts.width = { size: width, type: WidthType.DXA };
return new TableCell(opts);
}
// ── Table border helper ─────────────────────────────────────────────
const thinBorder = { style: BorderStyle.SINGLE, size: 4, color: "AAAAAA" };
const tableBorders = { top: thinBorder, bottom: thinBorder, left: thinBorder, right: thinBorder, insideHorizontal: thinBorder, insideVertical: thinBorder };
// ═══════════════════════════════════════════════════════════════════
// DOCUMENT CONTENT
// ═══════════════════════════════════════════════════════════════════
const children = [
// ── COVER / TITLE ────────────────────────────────────────────────
new Paragraph({
spacing: { before: 400, after: 80 },
alignment: AlignmentType.CENTER,
shading: { type: ShadingType.CLEAR, fill: DARK_GREEN },
children: [new TextRun({ text: "NUTRIGENOMICS DIETARY PROTOCOL", bold: true, color: WHITE, font: "Arial", size: 48 })]
}),
new Paragraph({
spacing: { before: 0, after: 40 },
alignment: AlignmentType.CENTER,
shading: { type: ShadingType.CLEAR, fill: DARK_GREEN },
children: [new TextRun({ text: "Liver Cancer Genetic Risk — Clinical Nutrition Framework", color: ACCENT, font: "Arial", size: 28, italics: true })]
}),
new Paragraph({
spacing: { before: 0, after: 400 },
alignment: AlignmentType.CENTER,
shading: { type: ShadingType.CLEAR, fill: DARK_GREEN },
children: [new TextRun({ text: "Prepared by: Nutrigenomics Clinical Team | Version 1.0 | 2026", color: "CCCCCC", font: "Arial", size: 20 })]
}),
...spacer(1),
// ── DISCLAIMER ───────────────────────────────────────────────────
callout("CLINICAL DISCLAIMER: This protocol is intended for use by qualified nutrigenomics practitioners in consultation with a hepatology-led multidisciplinary team. All recommendations must be individualised to confirmed genotyping results, current biochemistry, and active medical management. This document does not replace medical advice.", WARN_BG, true, WARN_RED),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 1 – PURPOSE AND SCOPE
// ══════════════════════════════════════════════════════════════
h1("1. PURPOSE AND SCOPE"),
body("This protocol provides a nutrigenomics-informed dietary framework for individuals with confirmed high genetic risk of hepatocellular carcinoma (HCC) or liver cancer. It integrates:"),
plainBullet("Genotype-directed dietary modifications based on known gene-nutrient interactions"),
plainBullet("Condition-specific guidance for hereditary liver diseases (hemochromatosis, Wilson's disease, alpha-1 antitrypsin deficiency)"),
plainBullet("Evidence-based chemoprevention through functional foods and phytochemicals"),
plainBullet("Avoidance strategies for dietary hepatotoxins and cancer-promoting compounds"),
...spacer(1),
body("This protocol is intended for practitioners and is not a standalone patient handout. Dietary implementation must follow genotyping, baseline labs, and consultation."),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 2 – REQUIRED BASELINE ASSESSMENT
// ══════════════════════════════════════════════════════════════
h1("2. REQUIRED BASELINE ASSESSMENT BEFORE DIETARY PLANNING"),
body("No dietary recommendations should be implemented without the following baseline data:", true),
...spacer(1),
h3("2.1 Genetic / Genotyping Panel"),
// Genotyping table
new Table({
width: { size: 9026, type: WidthType.DXA },
borders: tableBorders,
rows: [
new TableRow({ children: [
tc("Gene", ACCENT, true, WHITE, 2000),
tc("Variant(s) to Test", ACCENT, true, WHITE, 2400),
tc("Clinical Relevance", ACCENT, true, WHITE, 4626)
]}),
new TableRow({ children: [
tc("PNPLA3", LIGHT_GREEN, true),
tc("rs738409 (I148M)", LIGHT_GREEN),
tc("3-5x elevated NAFLD-to-HCC progression risk; drives dietary fat and fructose sensitivity")
]}),
new TableRow({ children: [
tc("TM6SF2"),
tc("rs58542926 (E167K)"),
tc("Impairs VLDL secretion; amplifies hepatic lipid accumulation under high-carbohydrate diet")
]}),
new TableRow({ children: [
tc("MBOAT7", LIGHT_GREEN),
tc("rs641738", LIGHT_GREEN),
tc("Increased hepatic phosphatidylinositol remodelling; associated with NAFLD and HCC risk")
]}),
new TableRow({ children: [
tc("HFE"),
tc("C282Y, H63D"),
tc("Hereditary hemochromatosis — drives iron overload and hepatocyte oxidative damage")
]}),
new TableRow({ children: [
tc("ATP7B", LIGHT_GREEN),
tc("Multiple pathogenic variants", LIGHT_GREEN),
tc("Wilson's disease — copper accumulation; hepatic inflammation and cirrhosis risk", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("SERPINA1"),
tc("Pi*Z, Pi*S alleles"),
tc("Alpha-1 antitrypsin deficiency — misfolded protein accumulation causes ER stress and hepatic fibrosis")
]}),
new TableRow({ children: [
tc("FADS1/FADS2", LIGHT_GREEN),
tc("rs174537, rs174575", LIGHT_GREEN),
tc("Determines ALA-to-EPA/DHA conversion efficiency; guides omega-3 source recommendation", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("CYP1A2 / CYP3A4"),
tc("Multiple variants"),
tc("Aflatoxin B1 bioactivation — slow metabolisers accumulate higher DNA adduct loads")
]}),
new TableRow({ children: [
tc("GSTM1 / GSTT1", LIGHT_GREEN),
tc("Null variants", LIGHT_GREEN),
tc("Impaired sulforaphane conjugation and phase II hepatic detoxification capacity", LIGHT_GREEN)
]}),
]
}),
...spacer(1),
h3("2.2 Biochemistry Baseline"),
plainBullet("Liver function tests: ALT, AST, GGT, ALP, bilirubin, albumin, INR"),
plainBullet("Ferritin, serum iron, transferrin saturation (hemochromatosis screening)"),
plainBullet("Ceruloplasmin, serum copper, 24-hour urine copper (Wilson's disease)"),
plainBullet("Alpha-1 antitrypsin level and phenotype (SERPINA1)"),
plainBullet("Fasting glucose, HbA1c, fasting insulin, HOMA-IR"),
plainBullet("Fasting lipid panel including triglycerides"),
plainBullet("25-hydroxyvitamin D"),
plainBullet("Homocysteine, serum folate, serum B12"),
plainBullet("AFP (alpha-fetoprotein) if HCC surveillance is active"),
plainBullet("Body composition assessment: BMI, waist circumference, DEXA or bioimpedance if available"),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 3 – CORE DIETARY FRAMEWORK
// ══════════════════════════════════════════════════════════════
h1("3. CORE DIETARY FRAMEWORK"),
body("The foundation of this protocol is a genotype-directed Mediterranean-style dietary pattern, modified for hepatic protection and anti-leukaemic chemoprevention."),
...spacer(1),
h3("3.1 Dietary Pattern — Mediterranean Base with Nutrigenomics Modifications"),
bullet("Foundation", "Extra-virgin olive oil as the primary fat source (3-4 tbsp/day) — oleocanthal and oleacein suppress NF-kB and IL-6, directly reducing hepatic inflammation"),
bullet("Protein sources", "Oily fish (3x/week), legumes (4-5x/week), eggs (daily), moderate poultry; minimise red meat to <1x/week, eliminate processed meat entirely"),
bullet("Carbohydrates", "Whole grains, legumes, and vegetables as primary carbohydrate sources; strict elimination of refined carbohydrates, white flour products, and added sugar"),
bullet("Vegetables", "Minimum 5-7 servings/day, emphasising cruciferous, allium, and colourful antioxidant-dense varieties"),
bullet("Fruit", "2 servings/day of low-fructose varieties (berries, citrus, kiwi); avoid fruit juice and dried fruit"),
bullet("Dairy", "Moderate fermented dairy (live-culture yogurt, kefir) for gut microbiome support; avoid full-fat cream and high-saturated-fat cheese in excess"),
bullet("Nuts and seeds", "Daily handful of mixed nuts — walnuts (omega-3), Brazil nuts (selenium, 1-2/day max), pumpkin seeds (zinc)"),
...spacer(1),
h3("3.2 Fructose and Added Sugar — Strict Restriction"),
callout("PRIORITY INTERVENTION: Fructose is the primary dietary driver of de novo hepatic lipogenesis, NAFLD progression, and HCC in genetically susceptible individuals.", WARN_BG, true, WARN_RED),
...spacer(1),
bullet("Target", "Eliminate all sugar-sweetened beverages (SSBs), fruit juice, and ultra-processed snacks entirely"),
bullet("Hidden fructose", "Check labels for: high-fructose corn syrup, sucrose, agave syrup, honey, fruit concentrate in processed foods"),
bullet("Whole fruit", "Limit to 1-2 servings/day of low-fructose options (berries, citrus); avoid mango, grapes, watermelon in excess"),
bullet("PNPLA3 I148M carriers", "Enhanced fructose sensitivity — even moderate fruit juice consumption amplifies hepatic lipid accumulation; stricter limit applies"),
bullet("TM6SF2 E167K carriers", "Impaired VLDL export compounds fructose-driven steatosis; added sugar restriction is non-negotiable"),
...spacer(1),
h3("3.3 Omega-3 Fatty Acids — Source Selection by Genotype"),
bullet("Preferred sources", "EPA/DHA-rich oily fish: salmon, sardines, mackerel, anchovies, herring (3x/week minimum)"),
bullet("FADS1/FADS2 variants", "Impaired conversion of plant-based ALA to EPA/DHA — flax, chia, and walnuts are insufficient as sole omega-3 sources for these clients; oily fish or algae-based DHA supplement is required"),
bullet("Mechanism", "EPA/DHA activate PPAR-alpha (anti-steatotic), suppress SREBP-1c (reduces lipogenesis), and reduce hepatic NF-kB-driven inflammation"),
bullet("Target", "Minimum 1.5-2g combined EPA+DHA per day from food; supplement with algae-derived DHA if fish intake is inadequate"),
...spacer(1),
h3("3.4 Coffee — First-Line Hepatoprotective Habit"),
callout("Coffee (2-4 cups/day) is among the most consistent dietary associations with reduced HCC risk and cirrhosis progression across multiple meta-analyses. This is a tier-1 recommendation.", LIGHT_GREEN, true, DARK_GREEN),
...spacer(1),
bullet("Target dose", "2-4 cups/day of brewed, espresso, or filter coffee"),
bullet("Mechanisms", "NRF2 pathway activation, NF-kB suppression, direct antifibrotic effect on hepatic stellate cells, HDAC inhibition (kahweol/cafestol diterpenes in unfiltered coffee)"),
bullet("Caffeinated vs decaf", "Both show benefit; caffeinated coffee shows stronger HCC risk reduction in studies"),
bullet("Caution", "Avoid adding sugar, flavoured syrups, or cream — defeats the hepatoprotective purpose; black or with unsweetened milk only"),
bullet("Wilson's disease", "Coffee contains trace copper — not a concern at 2-4 cups/day but avoid adding to other high-copper dietary load"),
...spacer(1),
h3("3.5 Cruciferous Vegetables and Phase II Detoxification Support"),
bullet("Target", "3-5 servings/week of broccoli, kale, Brussels sprouts, bok choy, cauliflower, radish"),
bullet("Preparation", "Lightly steam (5 min max) or consume raw — boiling leaches up to 60% of glucosinolates"),
bullet("Myrosinase trick", "Add raw mustard powder, daikon, or rocket to cooked broccoli to restore sulforaphane formation when myrosinase is heat-denatured"),
bullet("GSTM1/GSTT1 null carriers", "Reduced sulforaphane conjugation — higher dietary intake is especially important as compensatory strategy; also consider standardised broccoli sprout extract under supervision"),
bullet("Mechanisms", "Sulforaphane activates NRF2 → upregulates HO-1, NQO1, GST; I3C/DIM modulate AhR signalling relevant to hepatic detoxification"),
...spacer(1),
h3("3.6 Antioxidant and Polyphenol Priorities"),
bullet("Green tea (EGCG)", "2-3 cups/day — do not take with iron-rich meals as EGCG chelates non-haem iron; separate by 1-2 hours"),
bullet("Curcumin", "Fresh or dried turmeric in cooked meals + black pepper (piperine increases bioavailability ~2000%); anti-NF-kB and direct hepatoprotective"),
bullet("Resveratrol", "Red grapes, red berries, peanut skins — modest dietary amounts; dietary sources preferred over supplements unless under medical supervision"),
bullet("Anthocyanins", "1 cup/day dark berries (blueberries, blackberries, black currants) — anti-inflammatory, Akt/Erk pathway modulation"),
bullet("Quercetin", "Red onions, capers, apples — MDM2 inhibition, p53 stabilisation, apoptotic signalling"),
bullet("Selenium", "1-2 Brazil nuts/day (do not exceed — toxicity above 400mcg/day); sunflower seeds, eggs, tuna"),
bullet("Vitamin C", "From whole foods (citrus, bell pepper, kiwi, broccoli) — NOTE: vitamin C supplements are CONTRAINDICATED in hemochromatosis (see Section 4)"),
...spacer(1),
h3("3.7 Vitamin D — Test, Target, Recheck"),
bullet("Target", "Serum 25-OHD: 60-80 nmol/L; do not supplement to >100 nmol/L without medical review"),
bullet("Dietary sources", "Oily fish, egg yolks, fortified dairy — rarely sufficient alone; supplementation usually required"),
bullet("Mechanism", "VDR-mediated antifibrotic signalling in hepatic stellate cells; supports hepatic immune surveillance"),
bullet("Recheck", "Retest 25-OHD every 6 months while supplementing; dose-adjust to maintain target range"),
...spacer(1),
h3("3.8 Gut Microbiome Support"),
bullet("Prebiotic fibre", "Garlic, leeks, Jerusalem artichoke, chicory, oats, asparagus — promotes SCFA production (butyrate, propionate)"),
bullet("Fermented foods", "Daily serving of live-culture yogurt, kefir, kimchi, miso, or sauerkraut — modulates gut-liver axis inflammation"),
bullet("Mechanism", "Gut dysbiosis increases intestinal permeability → bacterial LPS translocation to portal circulation → hepatic TLR4 activation → NF-kB → fibrogenesis; a healthy microbiome reduces this axis"),
bullet("Fibre target", "Minimum 30g total dietary fibre/day from diverse plant sources"),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 4 – CONDITION-SPECIFIC MODULES
// ══════════════════════════════════════════════════════════════
h1("4. CONDITION-SPECIFIC NUTRIGENOMICS MODULES"),
h2("4A. Hereditary Hemochromatosis (HFE C282Y / H63D)"),
callout("Iron restriction is a clinical priority. Even modest dietary iron excess accelerates hepatocyte oxidative damage in HFE variant carriers.", WARN_BG, true, WARN_RED),
...spacer(1),
bullet("Avoid", "Red meat, organ meat (liver, kidney), blood sausage, iron-fortified cereals — all are high haem-iron sources with high bioavailability"),
bullet("Restrict", "Shellfish, legumes, dark chocolate (non-haem iron — absorption is lower but still meaningful at high intake)"),
bullet("CRITICAL: Vitamin C supplements CONTRAINDICATED", "Ascorbic acid dramatically increases non-haem iron absorption and promotes Fenton chemistry generating hydroxyl radicals in hepatocytes; dietary vitamin C from whole food is acceptable in moderation"),
bullet("Iron absorption inhibitors — use strategically", "Drink polyphenol-rich tea (green or black) with meals — tannic acid competitively inhibits iron absorption; calcium-rich foods at iron-containing meals also reduce uptake"),
bullet("Calcium", "Include dairy or fortified plant milk with meals to competitively inhibit iron absorption"),
bullet("Alcohol: ABSOLUTE ZERO", "Alcohol and iron overload share ROS-generating pathways in hepatocytes — the combination is exponentially more damaging than either alone; zero tolerance applies"),
bullet("Cooking", "Avoid cast iron cookware — measurable iron leaching into food occurs, especially with acidic ingredients"),
bullet("Monitoring", "Dietary adjustments must be guided by and tracked alongside therapeutic phlebotomy schedule and serial ferritin/transferrin saturation"),
...spacer(1),
h2("4B. Wilson's Disease (ATP7B Variants)"),
callout("Copper restriction is the dietary cornerstone. Always implement alongside and never instead of medical chelation or zinc therapy prescribed by the hepatologist.", WARN_BG, true, WARN_RED),
...spacer(1),
bullet("High-copper foods to avoid", "Shellfish especially oysters (highest dietary copper source), liver, kidney, chocolate, cocoa, nuts, mushrooms, dried legumes in excess"),
bullet("Moderate restriction", "Whole grains, seeds, dark leafy greens — copper content is moderate; do not eliminate but limit portion size"),
bullet("Water", "Test tap water copper content if plumbing includes copper pipes; use filtered water if levels are elevated"),
bullet("Cooking vessels", "Avoid copper cookware — leaching is significant, especially with acidic foods"),
bullet("Zinc-rich foods as adjunct", "Pumpkin seeds, legumes, eggs, hemp seeds — zinc competitively inhibits intestinal copper absorption via metallothionein induction; dietary zinc complements (but does not replace) medical zinc supplementation"),
bullet("Monitoring", "Track dietary changes alongside ceruloplasmin, serum copper, and 24-hour urine copper; liaise with hepatology team"),
...spacer(1),
h2("4C. Alpha-1 Antitrypsin Deficiency (SERPINA1 Pi*Z/Pi*S)"),
callout("The primary mechanism is ER stress from misfolded AAT protein accumulation in hepatocytes — not a systemic deficiency. Dietary strategy targets ER stress reduction and antioxidant compensation.", LIGHT_GREEN, false, DARK_GREEN),
...spacer(1),
bullet("Antioxidant priority", "Maximise hepatic glutathione via: cruciferous vegetables (NRF2/GST activation), high-sulphur foods (eggs, garlic, onions — cysteine for glutathione synthesis), selenium adequacy"),
bullet("Avoid hepatotoxic triggers", "Any compound requiring significant hepatic CYP metabolism can amplify ER stress; strictly avoid alcohol, unnecessary medications/supplements, and herbal hepatotoxins"),
bullet("Anti-ER stress nutrients", "Vitamin E (mixed tocopherols from nuts, seeds, olive oil) — reduces lipid peroxidation in ER membranes; omega-3s reduce inflammatory ER stress signalling"),
bullet("Protein intake", "Adequate protein is essential for liver regeneration capacity; target 1.2-1.5g/kg/day from lean sources (fish, legumes, eggs) — protein restriction is NOT indicated unless advanced cirrhosis with encephalopathy risk is confirmed by the hepatologist"),
bullet("Body weight", "Even modest weight gain amplifies ER stress and oxidative burden on already-stressed hepatocytes; weight stability or gradual loss if overweight is important"),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 5 – STRICT AVOIDANCE LIST
// ══════════════════════════════════════════════════════════════
h1("5. STRICT AVOIDANCE LIST — HEPATOTOXINS AND CANCER PROMOTERS"),
h3("5.1 Alcohol — Zero Tolerance"),
callout("ABSOLUTE CONTRAINDICATION in all genetic liver disease contexts. No safe threshold exists. Alcohol and genetic liver vulnerability share oxidative, inflammatory, and fibrogenic pathways — any intake compounds risk.", WARN_BG, true, WARN_RED),
...spacer(1),
bullet("Mechanism", "Acetaldehyde (toxic metabolite) directly crosslinks hepatic DNA; ethanol inhibits methionine synthase, depleting SAM and disrupting DNA methylation; promotes hepatic stellate cell activation and fibrosis"),
bullet("ALDH2 variants", "Clients with ALDH2*2 (common in East Asian populations) have severely impaired acetaldehyde clearance — even trivial alcohol intake generates disproportionate hepatotoxic and carcinogenic exposure"),
bullet("Applies to", "All alcohol-containing beverages including wine, beer, spirits; also 'low-alcohol' beverages and kombucha with residual alcohol content"),
...spacer(1),
h3("5.2 Aflatoxin B1 — Zero Tolerance"),
bullet("Sources", "Mould on improperly stored peanuts, maize, wheat, sorghum, dried figs, spices — especially in humid climates"),
bullet("Mechanism", "AFB1 bioactivated by CYP1A2/CYP3A4 to reactive epoxide → AFB1-N7-guanine adducts → TP53 R249S hotspot mutation found in 30-60% of HCC in high-exposure regions"),
bullet("CYP slow-metabolisers", "Carry higher adduct load per unit exposure — extra vigilance applies"),
bullet("Storage rule", "All nuts and grains: store in dry, cool, airtight containers; inspect before use; discard any with visible mould, musty smell, or colour change"),
bullet("Commercial products", "Choose reputable brands with aflatoxin testing certification where available"),
...spacer(1),
h3("5.3 Liver Fluke Risk"),
bullet("Raw freshwater fish", "Absolute avoidance — Opisthorchis/Clonorchis infection from raw or undercooked freshwater fish causes biliary inflammation and is a class 1 carcinogen for cholangiocarcinoma; especially relevant in Southeast Asian dietary contexts"),
bullet("Safe fish", "Marine (saltwater) fish is not a liver fluke risk; properly cooked freshwater fish is safe"),
...spacer(1),
h3("5.4 Dietary Environmental Hepatotoxins"),
bullet("Charred and barbecued meat", "Heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) are hepatic carcinogens; minimise char-grilling, use low-temperature cooking methods where possible"),
bullet("Cured and processed meats", "Nitrites/nitrosamines, benzene precursors — eliminate from diet"),
bullet("Ultra-processed foods", "AGEs (advanced glycation end-products), synthetic additives, emulsifiers — amplify hepatic oxidative stress and gut-liver axis inflammation"),
bullet("Pesticide residue", "Organophosphate and organochlorine pesticides impose hepatic CYP metabolic burden; prioritise organic for highest-residue produce (strawberries, spinach, apples, grapes, peaches)"),
...spacer(1),
h3("5.5 Contraindicated Supplements"),
new Table({
width: { size: 9026, type: WidthType.DXA },
borders: tableBorders,
rows: [
new TableRow({ children: [
tc("Supplement", WARN_RED, true, WHITE, 2500),
tc("Reason for Contraindication", WARN_RED, true, WHITE, 6526)
]}),
new TableRow({ children: [tc("Iron supplements", WARN_BG), tc("Promotes iron overload — absolute contraindication in hemochromatosis; avoid unless frank deficiency confirmed and hepatologist approves", WARN_BG)] }),
new TableRow({ children: [tc("Vitamin C supplements"), tc("Enhances iron absorption and promotes Fenton oxidative chemistry in hemochromatosis (HFE variants); contraindicated")] }),
new TableRow({ children: [tc("Kava kava (Piper methysticum)", WARN_BG), tc("Direct hepatotoxin — causes acute hepatitis and liver failure; banned/restricted in multiple countries; absolute contraindication", WARN_BG)] }),
new TableRow({ children: [tc("Comfrey (Symphytum)"), tc("Pyrrolizidine alkaloids cause hepatic veno-occlusive disease; severe hepatotoxicity")] }),
new TableRow({ children: [tc("Germander (Teucrium)", WARN_BG), tc("Diterpenoid compounds cause acute and chronic hepatotoxicity; withdrawn from market in many countries", WARN_BG)] }),
new TableRow({ children: [tc("High-dose green tea extract"), tc("Concentrated EGCG supplements (>800mg/day) associated with acute liver injury — dietary green tea is safe; supplements are not")] }),
new TableRow({ children: [tc("Any supplement >100mg niacin (as nicotinic acid)", WARN_BG), tc("Pharmacological niacin doses cause dose-dependent hepatotoxicity; dietary niacin from food is safe", WARN_BG)] }),
]
}),
...spacer(1),
callout("GENERAL RULE: No herbal supplement, traditional medicine, or nutraceutical should be taken without explicit approval from the hepatologist or supervising practitioner. The liver processes all ingested compounds and has significantly reduced reserve capacity in genetically susceptible individuals.", WARN_BG, true, WARN_RED),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 6 – WEIGHT MANAGEMENT AND METABOLIC HEALTH
// ══════════════════════════════════════════════════════════════
h1("6. WEIGHT MANAGEMENT AND METABOLIC HEALTH"),
body("Obesity-driven NAFLD represents a direct, stepwise pathway to HCC: steatosis → NASH → fibrosis → cirrhosis → HCC. Metabolic intervention is therefore cancer prevention."),
...spacer(1),
h3("6.1 Body Weight Targets"),
bullet("BMI target", "18.5-24.9 kg/m2; more practically, target reduction in waist circumference below 94cm (men) or 80cm (women) as proxy for visceral adiposity"),
bullet("Intrahepatic fat", "Independent of BMI, reducing intrahepatic fat content is the primary metabolic goal; even 5-7% body weight loss significantly reduces hepatic steatosis and NF-kB-driven inflammation"),
bullet("Bone marrow and visceral fat", "Anti-inflammatory dietary patterns reduce visceral adiposity independent of caloric restriction — Mediterranean adherence is sufficient as a strategy, not just calorie counting"),
...spacer(1),
h3("6.2 Meal Timing and Insulin / IGF-1 Management"),
bullet("Time-restricted eating", "14:10 or 16:8 pattern — reduces hepatic lipid accumulation and insulin resistance; activates AMPK and hepatic autophagy (mitophagy of damaged mitochondria)"),
bullet("Avoid late-night eating", "Hepatic lipid synthesis is circadian — eating in the late evening amplifies de novo lipogenesis even at identical caloric intake"),
bullet("Glycaemic pattern", "Low-glycaemic index meals, high-fibre carbohydrates — minimise postprandial insulin spikes and chronic IGF-1 elevation"),
bullet("FTO variant carriers", "Protein-adequate, lower-glycaemic dietary patterns show better weight maintenance outcomes than caloric restriction alone — protein at every meal reduces appetite via PYY/GLP-1"),
...spacer(1),
h3("6.3 Sarcopenic Obesity — Muscle Mass Preservation"),
bullet("Risk", "Sarcopenic obesity carries additive HCC risk beyond adiposity alone — muscle mass is an independent predictor of liver cancer outcomes"),
bullet("Protein target", "1.2-1.5g/kg body weight/day (unless advanced cirrhosis with encephalopathy — check with hepatology), emphasising leucine-rich sources: eggs, fish, legumes"),
bullet("Physical activity", "150-300 min/week moderate aerobic activity + 2x/week resistance training — independently reduces hepatic steatosis and NF-kB inflammatory signalling"),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 7 – SAMPLE DAILY EATING PATTERN
// ══════════════════════════════════════════════════════════════
h1("7. SAMPLE DAILY EATING PATTERN"),
body("The following is a representative template. Portions and specific foods must be adjusted to individual genotype, lab results, condition-specific restrictions, and cultural food preferences."),
...spacer(1),
new Table({
width: { size: 9026, type: WidthType.DXA },
borders: tableBorders,
rows: [
new TableRow({ children: [
tc("Meal", DARK_GREEN, true, WHITE, 1600),
tc("Example Foods", DARK_GREEN, true, WHITE, 4000),
tc("Key Nutrigenomics Purpose", DARK_GREEN, true, WHITE, 3426)
]}),
new TableRow({ children: [
tc("Breakfast", LIGHT_GREEN, true),
tc("Rolled oats with blueberries, walnuts, and ground flaxseed; 1-2 eggs scrambled with turmeric and black pepper; green tea or black coffee", LIGHT_GREEN),
tc("Beta-glucan (insulin), anthocyanins (Akt/Erk), ALA omega-3, choline; EGCG hepatoprotection; coffee — HCC risk reduction", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Mid-Morning"),
tc("1-2 Brazil nuts; apple or kiwi; additional black coffee (if within 4-cup daily limit)"),
tc("Selenium (GPx); low-fructose fruit; continued coffee benefit")
]}),
new TableRow({ children: [
tc("Lunch", LIGHT_GREEN, true),
tc("Large salad: dark leafy greens, rocket, red onion, cherry tomatoes, avocado, sardines or grilled salmon; EVOO + lemon dressing; wholegrain bread or lentils", LIGHT_GREEN),
tc("EPA/DHA (anti-steatotic); quercetin; lycopene; monounsaturated fat; folate; fibre", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Afternoon"),
tc("Live-culture yogurt or kefir with seeds; raw vegetable sticks (carrot, celery, bell pepper)"),
tc("Gut microbiome support; prebiotic fibre; carotenoids")
]}),
new TableRow({ children: [
tc("Dinner", LIGHT_GREEN, true),
tc("Lightly steamed broccoli + raw mustard; baked salmon or mackerel with garlic and olive oil; roasted sweet potato; side of kimchi or miso soup", LIGHT_GREEN),
tc("Sulforaphane (NRF2); EPA/DHA; allicin (hepatoprotective); beta-carotene; microbiome support", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Evening (optional)"),
tc("Small handful of mixed berries; chamomile or green tea (not within 1hr of iron-rich food)"),
tc("Antioxidant polyphenols; apigenin (HDAC inhibition); no additional caloric burden")
]}),
]
}),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 8 – MONITORING AND REVIEW
// ══════════════════════════════════════════════════════════════
h1("8. MONITORING, REVIEW, AND TEAM COORDINATION"),
h3("8.1 Recommended Review Schedule"),
new Table({
width: { size: 9026, type: WidthType.DXA },
borders: tableBorders,
rows: [
new TableRow({ children: [
tc("Timepoint", ACCENT, true, WHITE, 2000),
tc("Assessment", ACCENT, true, WHITE, 4000),
tc("Action", ACCENT, true, WHITE, 3026)
]}),
new TableRow({ children: [
tc("Baseline", LIGHT_GREEN),
tc("Full genotyping panel + biochemistry (see Section 2)", LIGHT_GREEN),
tc("Set personalised dietary protocol from this framework", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("4 weeks"),
tc("Diet diary review; early biochemistry if condition-specific (ferritin in HH)"),
tc("Identify adherence gaps; address palatability/cultural barriers")
]}),
new TableRow({ children: [
tc("3 months", LIGHT_GREEN),
tc("Repeat LFTs, ferritin/transferrin sat, fasting glucose, HbA1c, triglycerides, 25-OHD", LIGHT_GREEN),
tc("Dose-adjust vitamin D; assess metabolic response; update recommendations", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("6 months"),
tc("Full biochemistry review; body composition reassessment; diet quality scoring"),
tc("Reassess all modules; update condition-specific guidance")
]}),
new TableRow({ children: [
tc("12 months and annually", LIGHT_GREEN),
tc("Full reassessment including hepatology team review, AFP if indicated, imaging per surveillance protocol", LIGHT_GREEN),
tc("Longitudinal protocol update; integrate new evidence", LIGHT_GREEN)
]}),
]
}),
...spacer(1),
h3("8.2 Multidisciplinary Team Integration"),
plainBullet("Hepatologist: oversees HCC surveillance, fibrosis staging, therapeutic phlebotomy (hemochromatosis), and chelation (Wilson's)"),
plainBullet("Gastroenterologist: endoscopic surveillance where cirrhosis or portal hypertension is present"),
plainBullet("Nutrigenomics practitioner: this protocol — coordinates genotype-directed dietary personalisation and supplement safety"),
plainBullet("Genetic counsellor: family cascade testing for first-degree relatives of HFE, ATP7B, SERPINA1, and PNPLA3 variant carriers"),
plainBullet("Psychologist/health coach: dietary behaviour change support; adherence, food environment modification"),
plainBullet("GP/primary care: coordinates monitoring, referrals, and prescription supplements (e.g. vitamin D, zinc)"),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 9 – QUICK REFERENCE SUMMARY TABLE
// ══════════════════════════════════════════════════════════════
h1("9. QUICK REFERENCE — NUTRIGENOMICS SUMMARY TABLE"),
new Table({
width: { size: 9026, type: WidthType.DXA },
borders: tableBorders,
rows: [
new TableRow({ children: [
tc("Domain", DARK_GREEN, true, WHITE, 2000),
tc("Prioritise / Increase", DARK_GREEN, true, WHITE, 3513),
tc("Avoid / Eliminate", DARK_GREEN, true, WHITE, 3513)
]}),
new TableRow({ children: [
tc("Dietary Pattern", LIGHT_GREEN, true),
tc("Mediterranean base; EVOO; oily fish; legumes; whole grains; colourful vegetables", LIGHT_GREEN),
tc("Ultra-processed foods; red/processed meat; refined carbohydrates; added sugar", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Fructose/Sugar"),
tc("Berries, citrus (low-fructose whole fruit)"),
tc("SSBs, fruit juice, HFCS, agave, confectionery")
]}),
new TableRow({ children: [
tc("Omega-3", LIGHT_GREEN),
tc("Salmon, sardines, mackerel 3x/week; algae-based DHA if FADS variant", LIGHT_GREEN),
tc("Trans fats; excessive omega-6 vegetable oils", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Coffee"),
tc("2-4 cups/day black or unsweetened"),
tc("Adding sugar, flavoured syrups")
]}),
new TableRow({ children: [
tc("Antioxidants", LIGHT_GREEN),
tc("Dark berries, green tea, turmeric, red onion, tomato, nuts/seeds", LIGHT_GREEN),
tc("High-dose isolated antioxidant supplements without testing", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Cruciferous Veg"),
tc("Broccoli, kale, Brussels sprouts 3-5x/week; lightly steamed"),
tc("Boiling (loses glucosinolates)")
]}),
new TableRow({ children: [
tc("Alcohol", LIGHT_GREEN, true),
tc("-", LIGHT_GREEN),
tc("ALL alcohol — zero tolerance (absolute)", LIGHT_GREEN, true)
]}),
new TableRow({ children: [
tc("Aflatoxin"),
tc("Reputable brands; cool dry airtight storage for nuts/grains"),
tc("Mouldy nuts/grains; improperly stored produce")
]}),
new TableRow({ children: [
tc("Hemochromatosis", LIGHT_GREEN),
tc("Tea with meals (iron inhibition); calcium-rich foods at meals", LIGHT_GREEN),
tc("Red meat, offal, iron-fortified foods, Vit C supplements, cast iron cookware", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Wilson's Disease"),
tc("Zinc-rich foods (pumpkin seeds, legumes); filtered water"),
tc("Shellfish, liver, chocolate, nuts, copper cookware")
]}),
new TableRow({ children: [
tc("Supplements", LIGHT_GREEN),
tc("Vitamin D (to target 60-80 nmol/L); algae DHA if FADS variant; zinc if Wilson's (under supervision)", LIGHT_GREEN),
tc("Iron, Vit C (hemochromatosis), kava kava, comfrey, germander, high-dose green tea extract", LIGHT_GREEN)
]}),
new TableRow({ children: [
tc("Weight/Metabolic"),
tc("Lean protein 1.2-1.5g/kg; TRE 14:10 or 16:8; resistance training 2x/week"),
tc("Crash dieting (muscle loss); late-night eating")
]}),
]
}),
...spacer(1),
// ══════════════════════════════════════════════════════════════
// SECTION 10 – REFERENCES
// ══════════════════════════════════════════════════════════════
h1("10. KEY EVIDENCE BASE"),
body("This protocol is informed by the following evidence domains:"),
...spacer(1),
numBullet("Fakhar F et al. The Potential Role of Dietary Polyphenols in the Prevention and Treatment of Acute Leukemia. Nutrients. 2024;16(23):4100.", "refs"),
numBullet("Xiang Y, Wiemels JL, Nickels EM. The relationship of dietary folate, folic acid, and childhood cancer. Curr Probl Pediatr Adolesc Health Care. 2025 Sep. PMID: 41338873.", "refs"),
numBullet("PNPLA3 I148M variant and NAFLD-HCC progression: multiple cohort studies and meta-analyses (2018-2024).", "refs"),
numBullet("Coffee and HCC risk: systematic reviews and meta-analyses (Sang LX et al.; Kennedy OJ et al.; Johnson S et al.) demonstrating consistent 35-50% risk reduction at 2-4 cups/day.", "refs"),
numBullet("NRF2-sulforaphane axis in hepatic detoxification: Fahey JW, Talalay P et al. foundational work; multiple clinical and mechanistic studies (2010-2024).", "refs"),
numBullet("Omega-3 (EPA/DHA) and hepatic PPAR-alpha/SREBP-1c regulation: Sekiya M, Osuga J et al.; Calder PC review series.", "refs"),
numBullet("Aflatoxin B1 and TP53 R249S mutation in HCC: Groopman JD et al.; IARC Monographs Vol. 100F.", "refs"),
numBullet("Wilson's disease dietary management: European Association for the Study of the Liver (EASL) Clinical Practice Guidelines on Wilson's Disease.", "refs"),
numBullet("HFE hemochromatosis dietary guidance: EASL Clinical Practice Guidelines: Haemochromatosis (2022).", "refs"),
numBullet("Mediterranean diet and liver fibrosis: Kontogianni MD et al.; Trovato FM et al.", "refs"),
numBullet("Gut-liver axis and HCC: Schwabe RF, Greten TF. Gut microbiome in cancer: mechanistic insights. Nat Rev Cancer. 2020.", "refs"),
numBullet("Time-restricted eating and hepatic lipid metabolism: Chaix A et al.; Wilkinson MJ et al. Cell Metab. 2020.", "refs"),
...spacer(2),
// ── FOOTER CALLOUT ───────────────────────────────────────────
callout("This protocol is Version 1.0 (July 2026). It should be reviewed against emerging literature annually or when new genotyping evidence becomes available. Prepared by the Nutrigenomics Clinical Team. All clinical decisions require qualified practitioner oversight.", LIGHT_GREEN, false, DARK_GREEN),
];
// ═══════════════════════════════════════════════════════════════════
// BUILD DOCUMENT
// ═══════════════════════════════════════════════════════════════════
const doc = new Document({
numbering: {
config: [
{
reference: "bullets",
levels: [{
level: 0,
format: LevelFormat.BULLET,
text: "\u2022",
alignment: AlignmentType.LEFT,
style: { paragraph: { indent: { left: 540, hanging: 360 } } }
}]
},
{
reference: "numbers",
levels: [{
level: 0,
format: LevelFormat.DECIMAL,
text: "%1.",
alignment: AlignmentType.LEFT,
style: { paragraph: { indent: { left: 540, hanging: 360 } } }
}]
},
{
reference: "refs",
levels: [{
level: 0,
format: LevelFormat.DECIMAL,
text: "%1.",
alignment: AlignmentType.LEFT,
style: { paragraph: { indent: { left: 540, hanging: 360 } } }
}]
}
]
},
styles: {
default: {
document: { run: { font: "Arial", size: 20, color: DARK_TEXT } }
},
paragraphStyles: [
{
id: "Heading1", name: "Heading 1", basedOn: "Normal", next: "Normal", quickFormat: true,
run: { size: 28, bold: true, font: "Arial", color: WHITE },
paragraph: { spacing: { before: 300, after: 120 }, outlineLevel: 0 }
},
{
id: "Heading2", name: "Heading 2", basedOn: "Normal", next: "Normal", quickFormat: true,
run: { size: 24, bold: true, font: "Arial", color: WHITE },
paragraph: { spacing: { before: 200, after: 80 }, outlineLevel: 1 }
}
]
},
sections: [{
properties: {
page: {
margin: { top: 1080, bottom: 1080, left: 1080, right: 1080 }
}
},
headers: {
default: new Header({
children: [
new Paragraph({
alignment: AlignmentType.RIGHT,
shading: { type: ShadingType.CLEAR, fill: DARK_GREEN },
children: [
new TextRun({ text: "Nutrigenomics Dietary Protocol — Liver Cancer Genetic Risk ", font: "Arial", size: 16, color: "CCCCCC", italics: true })
]
})
]
})
},
footers: {
default: new Footer({
children: [
new Paragraph({
alignment: AlignmentType.CENTER,
children: [
new TextRun({ text: "Page ", font: "Arial", size: 16, color: "888888" }),
new TextRun({ children: [PageNumber.CURRENT], font: "Arial", size: 16, color: "888888" }),
new TextRun({ text: " | Version 1.0 | July 2026 | For Practitioner Use Only", font: "Arial", size: 16, color: "888888" })
]
})
]
})
},
children
}]
});
Packer.toBuffer(doc).then(buffer => {
fs.writeFileSync("/home/daytona/workspace/liver-cancer-protocol/Nutrigenomics_Liver_Cancer_Protocol.docx", buffer);
console.log("Document created successfully.");
});
Running Command
cd /home/daytona/workspace/liver-cancer-protocol && node generate.js 2>&1
Running Command
python3 /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/works…
Running Command
ls -lh /home/daytona/workspace/liver-cancer-protocol/Nutrigenomics_Liver_Cancer_…
Your document is ready for download:
Nutrigenomics Liver Cancer Protocol
Word Document · DOCX
Here is what the document contains across its 10 sections:
| Section | Content |
|---|---|
| 1. Purpose and Scope | Framework overview, intended use, practitioner guidance |
| 2. Baseline Assessment | Full genotyping panel table (PNPLA3, HFE, ATP7B, FADS1/2, CYP1A2, GSTM1 etc.) + biochemistry checklist |
| 3. Core Dietary Framework | Mediterranean base, fructose restriction, omega-3 by genotype, coffee, cruciferous veg, antioxidants, vitamin D, gut microbiome - all with mechanisms |
| 4. Condition-Specific Modules | Separate clinical modules for Hemochromatosis, Wilson's Disease, and Alpha-1 Antitrypsin Deficiency |
| 5. Strict Avoidance List | Alcohol (zero tolerance), aflatoxin, liver fluke, charred meats, pesticides + contraindicated supplements table (kava, iron, comfrey, germander, high-dose EGCG) |
| 6. Weight and Metabolic Health | Visceral/intrahepatic fat targets, time-restricted eating, sarcopenic obesity, FTO variant guidance |
| 7. Sample Daily Eating Pattern | Full-day meal template with nutrigenomics rationale per meal |
| 8. Monitoring and Review | Review schedule table (baseline to annual) + MDT coordination roles |
| 9. Quick Reference Summary | Single-page at-a-glance table covering all domains - Prioritise vs Avoid |
| 10. Evidence Base | 12 key evidence citations underpinning the protocol |
The document uses colour-coded section headers (deep green), warning callout boxes (red background) for zero-tolerance items, and formatted tables throughout - formatted for practitioner use with a running header and page footer.
Change the following recommendation for A CLIENT WITH HIGH GENETIC RISK OF LUNG CANCER : Eat cruciferous vegetables (broccoli, Brussels sprouts, cauliflower) regularly - sulforaphane supports lung detoxification enzymes Prioritize antioxidant-rich foods: berries, leafy greens, tomatoes (lycopene) Adequate vitamin D from food and safe sun exposure (low serum vitamin D is associated with worse lung outcomes) Do not take high-dose beta-carotene supplements - CARET and ATBC trials showed these increased lung cancer risk in smokers and asbestos-exposed individuals Take adequate folic acid in your diet.
Here are the nutrigenomics-reframed recommendations for a client with high genetic risk of lung cancer:
Nutrigenomics-Informed Dietary Recommendations
Client: High Genetic Risk of Lung Cancer
1. Cruciferous Vegetables — Genotype-Direct the Benefit
Original: Eat cruciferous vegetables regularly - sulforaphane supports lung detoxification enzymes.
Revised: The benefit of sulforaphane from broccoli, Brussels sprouts, kale, and watercress is strongly modulated by GSTM1 and GSTT1 genotype. Clients carrying null variants of GSTM1 (found in ~50% of the population) have impaired sulforaphane conjugation and Phase II enzyme induction — paradoxically, these clients derive the greatest chemoprevention benefit from high dietary intake because they rely more on food-derived NRF2 activation to compensate. Confirm GSTM1/GSTT1 null status and, if present, target 5-7 servings/week rather than general "regular" intake. Preparation matters critically: lightly steam only (5 minutes max) and add raw mustard powder or daikon radish to cooked broccoli to restore myrosinase activity and maximise sulforaphane yield. For GSTM1-null clients with known or past smoke/carcinogen exposure, standardised broccoli sprout extract (under practitioner supervision) may be appropriate as a clinical adjunct.
2. Antioxidants — Replace Broad Advice with Mechanistic Targeting
Original: Prioritise antioxidant-rich foods: berries, leafy greens, tomatoes.
Revised: Antioxidant selection should be guided by the client's NQO1, SOD2, and CYP1A1/1A2 genotype, which determine endogenous oxidative stress handling capacity in lung tissue. The following have lung-specific mechanistic evidence beyond general antioxidant activity:
- Lycopene (tomatoes, cooked especially): Downregulates IGF-1 signalling and NF-kB in lung epithelial cells. Cooking tomatoes in olive oil increases lycopene bioavailability 3-4 fold — raw tomatoes are significantly less effective. Target: cooked tomato-based foods 4-5x/week.
- Quercetin (red onions, capers, apples): Inhibits CYP1A1-mediated activation of polycyclic aromatic hydrocarbon (PAH) procarcinogens in lung tissue — directly relevant to clients with carcinogen exposure history. Also inhibits EGFR signalling relevant to NSCLC biology.
- EGCG — green tea (2-3 cups/day): Inhibits KRAS and EGFR downstream signalling, induces apoptosis in lung cancer cell lines, and activates NRF2 in bronchial epithelium. Do not take with iron-rich meals.
- Anthocyanins (blueberries, blackberries, cherries): Suppress NF-kB and STAT3 in lung tissue; 1 cup/day of mixed dark berries is a practical target.
- Resveratrol (red grapes, berries, peanut skins): Activates SIRT1-mediated DNA repair; anti-proliferative in lung adenocarcinoma models. Dietary amounts are modest but additive across the overall polyphenol load.
- Avoid isolated antioxidant supplements (vitamin E, selenium in high-dose form) without confirmed deficiency and testing — supplemental antioxidants at high doses have shown neutral to harmful signals in lung cancer prevention trials.
3. Vitamin D — Test, Target, and Understand the Genotype
Original: Adequate vitamin D from food and safe sun exposure.
Revised: "Adequate" is not actionable without knowing the client's VDR (BsmI, FokI, TaqI) and GC (vitamin D binding protein) genotype, which profoundly determine both circulating 25-OHD levels and tissue responsiveness to vitamin D. Clients with VDR FokI FF genotype have lower transcriptional activation efficiency — they may require higher circulating 25-OHD levels to achieve the same pulmonary immune surveillance benefit as FokI ff carriers.
- Test first: Measure serum 25-OHD. Target range for cancer-risk clients: 75-100 nmol/L (higher than standard population targets), based on epidemiological associations with lung cancer outcomes.
- Dietary sources are rarely sufficient alone: Oily fish (salmon, sardines, mackerel), egg yolks, and fortified dairy contribute meaningfully but cannot reliably achieve target levels without sun exposure or supplementation — especially in higher latitudes or dark-skinned clients.
- Supplementation: For clients not achieving target via diet and safe sun, D3 (cholecalciferol) supplementation at 1000-2000 IU/day is appropriate; retest every 6 months and dose-adjust. Do not recommend "safe sun exposure" without noting that UV exposure intensity, skin phototype, latitude, and season determine actual synthesis — vague guidance is insufficient for a high-risk client.
- Mechanism: VDR activation in lung tissue suppresses cell proliferation, supports alveolar macrophage antimicrobial and immune surveillance function, and reduces pro-inflammatory cytokine production relevant to carcinogenesis.
4. Beta-Carotene Supplements — Sharpen and Genotype-Contextualise the Warning
Original: Do not take high-dose beta-carotene supplements — CARET and ATBC trials showed increased lung cancer risk in smokers and asbestos-exposed individuals.
Revised: This warning is correct but must be deepened and broadened for a nutrigenomics-informed client:
- The CARET trial (beta-carotene 30mg + retinyl palmitate) and ATBC trial (beta-carotene 20mg) showed 18-28% increased lung cancer incidence in current smokers and asbestos-exposed individuals — not just elevated risk but a causal harm signal at supplemental doses.
- Extend the warning to all isolated carotenoid supplements: High-dose lycopene, lutein, or mixed carotenoid capsules have not been validated for safety in high-risk lung cancer clients and should not be taken without oncology/practitioner oversight.
- The genotype dimension: Clients carrying BCO1 (BCMO1) variants have impaired beta-carotene-to-retinol conversion. In smokers with BCO1 variants, circulating beta-carotene accumulates at higher levels per unit intake — supplemental beta-carotene is especially dangerous in this subgroup even at "moderate" doses.
- Whole food carotenoids are safe: Dietary beta-carotene from carrots, sweet potato, and orange/yellow vegetables has never shown harm and is associated with modest protective signals in non-smokers. The risk is entirely from supplemental, isolated, high-dose forms.
- Retinol (preformed vitamin A): High-dose preformed vitamin A supplements also carry lung-specific risk signals in smokers and should be avoided unless frank deficiency is confirmed.
5. Folate — Replace "Adequate Folic Acid" with Precision One-Carbon Nutrition
Original: Take adequate folic acid in your diet.
Revised: "Adequate folic acid" is the weakest recommendation on this list from a nutrigenomics standpoint. Lung carcinogenesis involves extensive aberrant DNA methylation of tumour suppressor genes — and folate is the single most important dietary regulator of the one-carbon methylation cycle. The recommendation must be both more specific and more nuanced:
- Establish MTHFR genotype (C677T, A1298C) first. If a hypomorphic variant is present, synthetic folic acid from fortified foods is only partially converted to active 5-MTHF — prioritise methylfolate-rich whole foods (dark leafy greens, lentils, asparagus, avocado, chickpeas) and consider a 5-methyltetrahydrofolate (5-MTHF) supplement rather than standard folic acid.
- Avoid very high-dose folic acid supplementation (>800mcg/day as synthetic form) without testing. Evidence suggests that pharmacological folic acid in the presence of pre-existing micro-neoplastic foci may promote tumour progression rather than prevent it — the pro-proliferative risk of excess folate in a client with already-elevated cancer risk is a genuine concern.
- Optimise the full methylation network: Folate alone is insufficient. Co-nutrients required include:
- Vitamin B12 (eggs, sardines, dairy): Required for methionine synthase; without B12, folate is trapped and SAM synthesis fails
- Vitamin B6 (poultry, chickpeas, bananas, sunflower seeds): Cofactor in serine hydroxymethyltransferase
- Riboflavin/B2 (eggs, almonds, dairy): MTHFR enzyme cofactor — especially important for MTHFR C677T TT homozygotes, where riboflavin adequacy partially rescues enzyme activity
- Choline (eggs, soybeans, liver): Alternative methyl donor, critical when folate is limiting
- Betaine (beetroot, quinoa, spinach): Direct methyl donor to the betaine-homocysteine methyltransferase pathway
- Monitor homocysteine as a functional biomarker of methylation cycle adequacy — elevated homocysteine (>10 µmol/L) indicates insufficient methyl donor support regardless of serum folate level.
Additional Nutrigenomics Recommendations Not in the Original List
6. Eliminate or Dramatically Reduce Processed and Cured Meats
Nitrosamines from processed meats are pulmonary carcinogens that bypass the liver and exert direct genotoxic effects in lung epithelium. CYP2A6 and CYP1A1 genotype determines metabolic activation rate of tobacco-specific nitrosamines (TSNAs) — fast metabolisers carry amplified risk. This is a tier-1 avoidance recommendation for any lung cancer risk client regardless of smoking status.
7. Omega-3 Fatty Acids for Pulmonary Anti-Inflammation
EPA and DHA reduce leukotriene B4 and prostaglandin E2 production in bronchial tissue, suppressing the chronic pulmonary inflammation that drives carcinogenic progression. Target 3 servings/week of oily fish (sardines, salmon, mackerel) or algae-based DHA if FADS1/FADS2 conversion variants are present. Evidence for omega-3s in lung cancer risk reduction is consistent across prospective cohort data.
8. Curcumin (Turmeric + Black Pepper) Daily
Curcumin inhibits NF-kB, AP-1, and STAT3 — three master transcription factors central to lung cancer cell survival and invasion. It is also a direct CYP1A1 inhibitor, reducing metabolic activation of PAH procarcinogens in lung tissue. Bioavailability is negligible without piperine (black pepper) or a lipid carrier — include in cooked meals with black pepper daily.
9. Zero Alcohol
Alcohol induces CYP2E1 in lung tissue, generating reactive oxygen species directly in bronchial epithelium. It also depletes the methylation cycle of folate and B12 simultaneously. For a client with high genetic lung cancer risk — particularly those with any past smoke or carcinogen exposure — no safe alcohol threshold exists.
10. Reduce Ultra-Processed Foods and Dietary AGEs
Advanced glycation end-products (AGEs) in fried, grilled, and ultra-processed foods activate RAGE (receptor for AGEs) in pulmonary tissue, driving NF-kB-mediated chronic inflammation — the same inflammatory axis that promotes bronchial carcinogenesis. A whole-food dietary pattern dramatically reduces AGE burden independently of any specific nutrient.
Practitioner note: Implement after confirming GSTM1/GSTT1, MTHFR, VDR, BCO1, CYP1A1, and CYP2A6 genotype status. Baseline labs should include serum 25-OHD, homocysteine, serum folate, B12, and a full inflammatory marker panel. This framework is adjunctive to active medical surveillance and does not replace it.
write 10 recommendation and summerize above content
Nutrigenomics Dietary Recommendations
High Genetic Risk of Lung Cancer — 10-Point Summary
1. Cruciferous Vegetables — Genotype-Directed Dose and Preparation
Target 5-7 servings/week of broccoli, Brussels sprouts, kale, and watercress. Clients with GSTM1/GSTT1 null variants (present in ~50% of the population) have impaired sulforaphane metabolism and depend more heavily on dietary NRF2 activation for lung detoxification — higher intake is especially critical for them. Always lightly steam (5 min max) and add raw mustard powder or daikon to cooked broccoli to restore myrosinase activity and maximise sulforaphane yield.
2. Mechanistic Antioxidant Selection — Not Just "Eat Colourful Foods"
Prioritise antioxidants with lung-specific mechanisms: cooked tomatoes in olive oil (lycopene — 3-4x higher bioavailability than raw; suppresses IGF-1 and NF-kB in lung epithelium), green tea 2-3 cups/day (EGCG — inhibits KRAS/EGFR downstream signalling), 1 cup dark berries daily (anthocyanins — suppress STAT3 and NF-kB), and quercetin from red onions and apples (inhibits CYP1A1-mediated PAH procarcinogen activation in lung tissue). Guide antioxidant emphasis by NQO1 and CYP1A1 genotype status.
3. Vitamin D — Test First, Then Target 75-100 nmol/L
Confirm VDR genotype (BsmI, FokI, TaqI) and GC (vitamin D binding protein) variants before recommending dose. VDR FokI FF carriers have reduced transcriptional efficiency and may need higher circulating levels to achieve equivalent pulmonary immune surveillance benefit. Test serum 25-OHD; supplement with D3 (1000-2000 IU/day) if below target; use oily fish, egg yolks, and fortified dairy as dietary foundations; retest every 6 months and dose-adjust. Vague "safe sun exposure" advice is insufficient for a high-risk client.
4. Absolute Ban on Beta-Carotene and Isolated Carotenoid Supplements
The CARET and ATBC trials demonstrated 18-28% increased lung cancer incidence with supplemental beta-carotene in smokers and asbestos-exposed individuals — a causal harm signal, not merely an association. Extend this prohibition to all high-dose isolated carotenoid supplements (lycopene capsules, mixed carotenoid tablets). Clients with BCO1 (BCMO1) variants have impaired beta-carotene conversion and accumulate higher circulating levels per unit intake, amplifying the risk further. Whole-food carotenoids from carrots, sweet potato, and orange/yellow vegetables remain safe and beneficial.
5. Precision One-Carbon Nutrition — Beyond "Adequate Folic Acid"
Establish MTHFR C677T and A1298C genotype before recommending folate form or dose. If a hypomorphic variant is present, prioritise methylfolate-rich whole foods (dark leafy greens, lentils, asparagus, avocado) and use 5-MTHF supplemental form rather than synthetic folic acid. Avoid very high-dose folic acid (>800 mcg/day) in clients with any existing micro-neoplastic risk — excess folate may promote rather than suppress tumour progression. Support the full methylation network: B12 (sardines, eggs, dairy), B6 (chickpeas, poultry, sunflower seeds), riboflavin/B2 (especially for MTHFR TT homozygotes, where B2 adequacy partially rescues enzyme activity), choline (eggs, soybeans), and betaine (beetroot, quinoa). Monitor homocysteine as a functional biomarker of methylation adequacy — target below 10 µmol/L.
6. Omega-3 Fatty Acids for Pulmonary Anti-Inflammation
EPA and DHA reduce leukotriene B4 and prostaglandin E2 in bronchial tissue, suppressing the chronic pulmonary inflammation that drives carcinogenic progression. Target 3 servings/week of oily fish (salmon, sardines, mackerel). Clients with FADS1/FADS2 conversion variants cannot efficiently convert plant-based ALA (flax, chia, walnuts) to EPA/DHA — oily fish or algae-derived DHA supplement is the reliable route for these individuals.
7. Curcumin Daily — Bioavailability-Conscious Delivery
Curcumin inhibits NF-kB, AP-1, and STAT3, three master transcription factors central to lung cancer cell survival and invasion. It also directly inhibits CYP1A1, reducing metabolic activation of PAH procarcinogens in lung tissue. Bioavailability without a carrier is negligible — include fresh or dried turmeric in cooked meals with black pepper (piperine increases bioavailability ~2000%) and a fat source daily. This is a practical, low-cost, high-impact daily habit.
8. Zero Alcohol
Alcohol induces CYP2E1 in lung tissue, generating reactive oxygen species directly in bronchial epithelium. It simultaneously depletes folate and B12, disrupting the methylation cycle that protects tumour suppressor gene expression. For a client with high genetic lung cancer risk — especially with any past or present smoke or occupational carcinogen exposure — no safe intake threshold exists. The recommendation must be unambiguous and absolute.
9. Eliminate Processed and Cured Meats; Minimise Dietary AGEs
Nitrosamines from processed meats are pulmonary carcinogens that exert direct genotoxic effects in lung epithelium. CYP2A6 fast-metaboliser variants generate more carcinogenic nitrosamine metabolites per unit exposure — genotype amplifies this risk. Separately, advanced glycation end-products (AGEs) from fried, grilled, and ultra-processed foods activate RAGE in pulmonary tissue, driving the same NF-kB inflammatory axis that underpins bronchial carcinogenesis. Use low-temperature cooking methods; replace processed meat with fish, legumes, and eggs as primary protein sources.
10. Pesticide-Conscious Produce Selection and Environmental Toxin Minimisation
CYP1A1 and GSTM1 genotype variants that impair carcinogen detoxification in lung tissue also reduce clearance of organochlorine and organophosphate pesticides — compounds with independent lung carcinogen associations. Prioritise organic for highest-residue produce (strawberries, spinach, apples, grapes). Beyond diet, this client requires a full environmental exposure audit: radon (highest residential lung cancer risk factor after smoking), indoor air quality, occupational exposures, and cooking fume exposure — all of which interact with genetic detoxification capacity in the same CYP/GST pathways targeted by dietary intervention.
Summary
| # | Recommendation | Key Genotype | Action |
|---|---|---|---|
| 1 | Cruciferous vegetables 5-7x/week | GSTM1/GSTT1 null | Lightly steam + add raw mustard; higher dose if null variant |
| 2 | Mechanistic antioxidants | NQO1, CYP1A1 | Cooked tomato, green tea, dark berries, quercetin |
| 3 | Vitamin D to target 75-100 nmol/L | VDR FokI, GC | Test first; D3 supplement; recheck 6-monthly |
| 4 | No beta-carotene or carotenoid supplements | BCO1 variants | Whole-food carotenoids only; supplements are contraindicated |
| 5 | Precision folate — full methylation network | MTHFR C677T/A1298C | 5-MTHF form if variant; add B2, B12, B6, choline, betaine |
| 6 | Omega-3s 3x/week oily fish | FADS1/FADS2 | Algae-DHA if poor converter; targets bronchial inflammation |
| 7 | Curcumin + black pepper daily | CYP1A1 | In cooked meals with fat; inhibits PAH activation |
| 8 | Zero alcohol | ALDH2, CYP2E1 | Absolute; no threshold is safe for this risk profile |
| 9 | No processed meat; reduce dietary AGEs | CYP2A6 | Fish, legumes, eggs as protein base; low-temp cooking |
| 10 | Organic produce + environmental audit | CYP1A1, GSTM1 | Radon test; occupational review; cooking fume reduction |
These 10 recommendations shift the framework from generic dietary advice to a genotype-informed, mechanism-directed protocol. Implementation should follow confirmation of key variants (GSTM1/GSTT1, MTHFR, VDR, BCO1, CYP1A1, FADS1/2), baseline labs (25-OHD, homocysteine, B12, folate, inflammatory markers), and integration with the client's active medical surveillance programme.
This is a shared conversation. Sign in to Orris to start your own chat.